Trial Profile
A confirmatory phase II trial to investigate a modified formulation of Tardoxal (pyridoxal phosphate) for tardive dyskinesia
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 13 Jan 2016
Price :
$35
*
At a glance
- Drugs Pyridoxal phosphate (Primary)
- Indications Drug-induced dyskinesia
- Focus Therapeutic Use
- 13 Jan 2016 New trial record